| AIZ |
Report |
Adjusted EPS |
BEAT |
pred ~$5.28 vs. cons $5.16 |
MEDIUM |
| AIZ |
Report |
Adjusted EBITDA excluding reportable catastrophes |
BEAT |
pred ~$419M vs. cons $414M |
MEDIUM |
| AIZ |
Report |
Global Lifestyle adjusted EBITDA |
BEAT |
pred ~$221M vs. cons $218M |
MEDIUM |
| AIZ |
Guide |
Adjusted EBITDA excluding reportable catastrophes |
BETTER |
guide ~$1.79B vs. cons $1.78B (FY2026) |
MEDIUM |
| AIZ |
Guide |
Adjusted EPS excluding reportable catastrophes |
BETTER |
guide ~$23.55 vs. cons $23.45 (FY2026) |
LOW |
| AIZ |
Guide |
Global Lifestyle adjusted EBITDA |
UNCHANGED |
guide ~$881M vs. cons $881M (FY2026) |
HIGH |
| AIZ |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.2% |
— |
MEDIUM |
| AIZ |
Return |
5-day cumulative residual |
+1.0% (FADE) |
A modest quarter beat supports a +2.2% day-1 residual, but FY2026 adjusted EPS guidance of ~$23.55 versus consensus of $23.45 implies limited out-period revisions, causing the cumulative residual to fade toward +1.0% by day 5. |
MEDIUM |